[Prevention of NSAID-induced gastric lesions: H2 antagonists or misoprostol? A meta-analysis of controlled clinical studies].
Capurso
L
L
Serv. Gastroenterologia ed Endoscopia Digestiva, Ospedale S. Filippo Neri di Roma.
Koch
M
M
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004381:Duodenal Ulcer / Q000517:prevention & control; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D015201:Meta-Analysis as Topic; D016595:Misoprostol / Q000627:therapeutic use*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D013272:Stomach Diseases / Q000139:chemically induced / Q000517:prevention & control*; D013276:Stomach Ulcer / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006635:Histamine H2 Antagonists; D016595:Misoprostol
La prevenzione del danno gastrico da FANS: H2 antagonisti o misoprostol? Una meta-analisi degli studi clinici controllati.